Showing results (41-50 of 89) with videos related to
Sort By:
Pageof 9
Journal of Clinical Medicine|January 21, 2023
Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA StudyThomas Jouve, Mélanie Daligault, Johan Noble, et al.Kidney International Reports|June 20, 2024
Evaluation of Torque Teno Virus DNA Load as a Predictive Biomarker in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to BelataceptLara Cabezas, Aurelie Truffot, Raphaele Germi, et al.Journal of Clinical Medicine|January 11, 2022
Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing DesensitizationAurélie Truffot, Thomas Jouve, Johan Noble, et al.Journal of Clinical Medicine|August 27, 2021
Protocol Biopsies on de novo Renal-Transplants at 3 Months after Surgery: Impact on 5-Year Transplant SurvivalFlorian Terrec, Johan Noble, Hamza Naciri-Bennani, et al.Clinical Biochemistry|December 31, 2022
Quantification of belatacept by liquid chromatography-tandem mass spectrometry in human plasma: Application to a pharmacokinetic study in renal transplant recipientsAurélie Truffot, Jean-François Jourdil, Elodie Veyret-Gautier, et al.Journal of Clinical Apheresis|March 30, 2021
Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorptionThomas Jouve, Raphaël Marlu, Hamza Naciri Bennani, et al.Journal of Personalized Medicine|March 28, 2024
Is There a Place for Apheresis in the Management of Idiopathic Membranous Nephropathy? A Report of Three Cases and Literature ReviewHamza Naciri Bennani, Augustin Twite Banza, Diane Giovannini, et al.Transplantation Direct|February 13, 2020
Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic ParametersFlorian Terrec, Thomas Jouve, Hamza Naciri-Bennani, et al.Journal of Clinical Apheresis|August 2, 2021
How to improve clotting factors depletion in double-filtration plasmapheresisHamza Naciri Bennani, Raphael Marlu, Florian Terrec, et al.Transplantation Direct|April 29, 2021
Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant CandidatesMélanie Daligault, Béatrice Bardy, Johan Noble, et al.Pageof 9